PPARGC1A and colonic neoplasm: Secondly, we studied the expression and pathophysiological significance of CYP19A1 in vitro and in vivo, and further studies are needed on other LMGs including FABP4, LRP2, SLCO1A2, PPARGC1A and ALOXE3 in colon cancer.